Am. J. Respir. Cell Mol. Biol., Vol 10, No. 5, May 1994, 538-545.
Use of mucin antibodies and cDNA probes to quantify hypersecretion in vivo in human airways
D Steiger, J Fahy, H Boushey, WE Finkbeiner and C Basbaum
Department of Anatomy, University of California, San Francisco 94143.
Mucus hypersecretion is a prominent feature of the airway's response to
injury. The ability to quantitatively detect mucin and mucin mRNA in vivo
in human airways would facilitate the determination of safe exposure levels
to various air pollutants and the identification of drugs capable of
attenuating mucus hypersecretion. To this end, we have developed two
assays: an enzyme-linked immunosorbent assay (ELISA) quantifying mucin-like
molecules and a polymerase chain reaction (PCR)- based assay quantifying
mucin mRNA. These tests are performed on bronchial lavage fluid and
epithelial cells brushed from the surfaces of human airways at
bronchoscopy. The PCR data are normalized to eliminate potentially
confounding effects of nonepithelial cells in the samples. In a study of
six smokers and six nonsmokers, the ELISA detected significantly more
mucin-like material in the airways of the smokers than of the nonsmokers.
The median mucin concentration for the smokers was 52.2 micrograms/ml
(range, 16.3 to 4,860.0), whereas that for the nonsmokers was 12.7
micrograms/ml (range, 4.5 to 22.9). The difference between smokers and
nonsmokers was statistically significant (P < or = 0.01). The PCR-based
test showed a trend for RNA samples from smokers to be enriched (vis-a-vis
nonsmokers) in mucin mRNA.
This article has been cited by other articles:

|
 |

|
 |
 
S. H. Randell, R. C. Boucher, and for the University of North Carolina Virtual Lung
Effective Mucus Clearance Is Essential for Respiratory Health
Am. J. Respir. Cell Mol. Biol.,
July 1, 2006;
35(1):
20 - 28.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. K. Gipson, R. Moccia, S. Spurr-Michaud, P. Argüeso, A. R. Gargiulo, J. A. Hill III, G. D. Offner, and H. T. Keutmann
The Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle
J. Clin. Endocrinol. Metab.,
February 1, 2001;
86(2):
594 - 600.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Louahed, M. Toda, J. Jen, Q. Hamid, J.-C. Renauld, R. C. Levitt, and N. C. Nicolaides
Interleukin-9 Upregulates Mucus Expression in the Airways
Am. J. Respir. Cell Mol. Biol.,
June 1, 2000;
22(6):
649 - 656.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. A. MARCHBANKS, H. WILSON, E. BASTOS, D. W. CRAMER, J. M. SCHILDKRAUT, and H. B. PETERSON
Cigarette Smoking and Epithelial Ovarian Cancer by Histologic Type
Obstet. Gynecol.,
February 1, 2000;
95(2):
255 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Berger, J. A. Voynow, K. W. Peters, and M. C. Rose
Respiratory Carcinoma Cell Lines . MUC Genes and Glycoconjugates
Am. J. Respir. Cell Mol. Biol.,
March 1, 1999;
20(3):
500 - 510.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. N Baraniuk, G. Wong, M. Ali, M. Sabol, and T. Troost
Glucocorticoids decrease c-fos expression in human nasal polyps in vivo
Thorax,
July 1, 1998;
53(7):
577 - 582.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1994 American Thoracic Society.
|
|
|